Vasopressin aggravates cardiopulmonary bypass-induced gastric mucosal ischemia

European Surgical Research

Volumn 54, Issue 1-2, 2015, Pages 75-86

  Bomberg, Hagen ^a   Bierbach, Benjamin ^a   Flache, Stephan ^a   Novák, Matous ^a   Bandner Risch, Doris ^a   Menger, Michael D ^a   Schäfers, Hans Joachim ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Apoptosis; Cardiopulmonary bypass; Endothelin receptors; Gastric microcirculation; Upper gastrointestinal bleeding

Indexed keywords

CASPASE 3; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; MYELOPEROXIDASE; VASOPRESSIN; ENDOTHELIN; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERIAL OXYGEN SATURATION; ARTICLE; CARDIOPULMONARY BYPASS; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG MEGADOSE; GASTRIC MUCOSA ISCHEMIA; HEMODYNAMICS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MEAN ARTERIAL PRESSURE; MICROCIRCULATION; MICROVASCULAR ISCHEMIA; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REPERFUSION INJURY; STOMACH MUCOSA; STOMACH MUCOSA BLOOD FLOW; STOMACH MUCOSA INJURY; TISSUE PERFUSION; ADVERSE EFFECTS; ANIMAL; DRUG EFFECTS; METABOLISM; PIG; RANDOMIZATION; VASCULARIZATION;

ANIMALS; CARDIOPULMONARY BYPASS; ENDOTHELINS; GASTRIC MUCOSA; HEMODYNAMICS; ISCHEMIA; MICROCIRCULATION; RANDOM ALLOCATION; SWINE; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 84927797202     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000368355     Document Type: Article

References (36)

1. Rodriguez F, Nguyen TC, Galanko JA, Morton J. Gastrointestinal complications after coronary artery bypass grafting: a national study of morbidity and mortality predictors. J Am Coll Surg 2007; 205: 741-747.
2. Brzozowski T, Konturek PC, Sliwowski Z, Kwiecien S, Drozdowicz D, Pawlik M, Mach K, Konturek SJ, Pawlik WW. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals. J Physiol Pharmacol 2006; 57(suppl 3): 67-79.
3. Ramakrishnan K, Salinas RC. Peptic ulcer disease. Am Fam Physician 2007; 76: 1005-1012.
4. Fan H, Zheng Z, Feng W, Wang W, Song Y, Lin Y, Hu S. Risk factors and prevention of upper gastrointestinal hemorrhage after a coronary artery bypass grafting operation. Surg Today 2010; 40: 931-935.
5. O'Dwyer C, Woodson LC, Conroy BP, Lin CY, Deyo DJ, Uchida T, Johnston WE. Regional perfusion abnormalities with phenylephrine during normothermic bypass. Ann Thorac Surg 1997; 63: 728-735.
6. Ohri SK, Bowles CT, Siddiqui A, Khaghani A, Keogh BE, Wright G, Yacoub MH, Taylor KM. The effect of cardiopulmonary bypass on gastric and colonic mucosal perfusion: a tonometric assessment. Perfusion 1994; 9: 101-108.
7. Bomberg H, Bierbach B, Flache S, Wagner I, Glaser L, Groesdonk HV, Menger MD, Schafers HJ. Endothelin and vasopressin influence splanchnic blood flow distribution during and after cardiopulmonary bypass. J Thorac Cardiovasc Surg 2013; 145: 539-547.
8. Ohri SK, Velissaris T. Gastrointestinal dysfunction following cardiac surgery. Perfusion 2006; 21: 215-223.
9. Karzai W, Lotte A, Gunnicker M, Vorgrimler-Karzai UM, Priebe HJ. Dobutamine increases oxygen consumption during constant flow cardiopulmonary bypass. Br J Anaesth 1996; 76: 5-8.
10. Lindström E, Björkqvist M, Boketoft A, Chen D, Zhao CM, Kimura K, Håkanson R. Neurohormonal regulation of histamine and pancreastatin secretion from isolated rat stomach ECL cells. Regul Pept 1997; 71: 73-86.
11. Lindström E, Håkanson R. Neurohormonal regulation of secretion from isolated rat stomach ECL cells: a critical reappraisal. Regul Pept 2001; 97: 169-180.
12. Whittle BJ, Lopez-Belmonte J. Interactions between the vascular peptide endothelin-1 and sensory neuropeptides in gastric mucosal injury. Br J Pharmacol 1991; 102: 950-954.
13. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-Time quantitative PCR and the 2-CT method. Methods 2001; 25: 402-408.
14. Natale G, Lazzeri G, Blandizzi C, Gherardi G, Lenzi P, Pellegrini A, Del Tacca M. Seriate histomorphometry of whole rat stomach: an accurate and reliable method for quantitative analysis of mucosal damage. Toxicol Appl Pharmacol 2001; 174: 17-26.
15. Groesdonk HV, Klingele M, Schlempp S, Bomberg H, Schmied W, Minko P, Schäfers HJ. Risk factors for nonocclusive mesenteric ischemia after elective cardiac surgery. J Thorac Cardiovasc Surg 2013; 145: 1603-1610.
16. Nygren A, Thoren A, Ricksten SE. Vasopressin decreases intestinal mucosal perfusion: a clinical study on cardiac surgery patients in vasodilatory shock. Acta Anaesthesiol Scand 2009; 53: 581-588.
17. Hiltebrand LB, Krejci V, Jakob SM, Takala J, Sigurdsson GH. Effects of vasopressin on microcirculatory blood flow in the gastrointestinal tract in anesthetized pigs in septic shock. Anesthesiology 2007; 106: 1156-1167.
18. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-415.
19. Whittle BJ, Esplugues JV. Induction of rat gastric damage by the endothelium-derived peptide, endothelin. Br J Pharmacol 1988; 95: 1011-1013.
20. Mizuguchi T, Nishiyama M, Moroi K, Tanaka H, Saito T, Masuda Y, Masaki T, De Wit D, Yanagisawa M, Kimura S. Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse. Br J Pharmacol 1997; 120: 1427-1430.
21. Maeda S, Miyauchi T, Iemitsu M, Tanabe T, Irukayama-Tomobe Y, Goto K, Yamaguchi I, Matsuda M. Involvement of endogenous endothelin-1 in exercise-induced redistribution of tissue blood flow: an endothelin receptor antagonist reduces the redistribution. Circulation 2002; 106: 2188-2193.
22. Padol I, Huang JQ, Hunt RH. Anti-ulcerogenic properties of endothelin receptor antagonists in the rat. Aliment Pharmacol Ther 1999; 13: 537-544.
23. Kirigiti P, Bai Y, Yang YF, Li X, Li B, Brewer G, Machida CA. Agonist-mediated down-regulation of rat beta1-adrenergic receptor transcripts: role of potential post-Transcriptional degradation factors. Mol Pharmacol 2001; 60: 1308-1324.
24. Tomobe Y, Yanagisawa M, Fujimori A, Masaki T, Goto K. Arginine-vasopressin increases the release of ET-1 into perfusate of rat mesenteric artery. Biochem Biophys Res Commun 1993; 191: 654-661.
25. Roubert P, Gillard V, Plas P, Guillon JM, Chabrier PE, Braquet P. Angiotensin II and phorbol-esters potently down-regulate endothelin (ET-1) binding sites in vascular smooth muscle cells. Biochem Biophys Res Commun 1989; 164: 809-815.
26. Barberis C, Mouillac B, Durroux T. Structural bases of vasopressin/oxytocin receptor function. J Endocrinol 1998; 156: 223-229.
27. Holt DB, Delaney RR, Uyehara CF. Effects of combination dobutamine and vasopressin therapy on microcirculatory blood flow in a porcine model of severe endotoxic shock. J Surg Res 2009; 171: 191-198.
28. Hinohara H, Kadoi Y, Tokue A, Saito S, Kawauchi C, Mizutani A. Comparison of the effects of vasopressin and norepinephrine on organ perfusion during septic shock in streptozotocin-induced diabetic rats. J Anesth 2010; 24: 553-563.
29. Guzman JA, Rosado AE, Kruse JA. Vasopressin vs norepinephrine in endotoxic shock: systemic, renal, and splanchnic hemodynamic and oxygen transport effects. J Appl Physiol 2003; 95: 803-809.
30. Wilson SE, Fisher SL, Hiatt JR, Winston MA. Effect of vasopressin on mesenteric blood flow determined by the clearance of radioxenon. J Surg Res 1976; 20: 237-242.
31. Monstein HJ, Truedsson M, Ryberg A, Ohlsson B. Vasopressin receptor mRNA expression in the human gastrointestinal tract. Eur Surg Res 2008; 40: 34-40.
32. Bichet DG, Razi M, Lonergan M, Arthus MF, Papukna V, Kortas C, Barjon JN. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med 1988; 318: 881-887.
33. Haslam RJ, Rosson GM. Aggregation of human blood platelets by vasopressin. Am J Physiol 1972; 223: 958-967.
34. Caltabiano S, Brennan FT, Kinter LB. In vitro inhibition of gastric acid secretion by vasopressin. Eur J Pharmacol 1987; 139: 281-286.
35. Ghosh MN. A quantitative method for the assay of inhibitors of acid gastric secretion in the rat. Br J Pharmacol Chemother 1958; 13: 118-124.
36. Said SA, El-Mowafy AM. Role of endogenous endothelin-1 in stress-induced gastric mucosal damage and acid secretion in rats. Regul Pept 1998; 73: 43-50.